Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging (Amsterdam)
Effect of Transmyocardial Laser Revascularization on Myocardial Perfusion and Left Ventricular Structure by Cardiovascular Magnetic Resonance Imaging and Dynamic Volumetric Computed Tomography
Sponsor: Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
Terminated
Lack of patient population
Other terminated trials from Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
More terminations from Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
A NA clinical study on Angina and Chest Pain, this trial is terminated or withdrawn. The trial is conducted by Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.
- Piedmont Healthcare
For direct contact, visit the study record on ClinicalTrials.gov .